It fell $0.29, placing it 46th among the top 50 biggest swings in Wall Street during the time frame.
Shares in PhaseBio Pharmaceuticals Inc. finished on April 18 at $1.23.
PhaseBio Pharmaceuticals Inc. employs 60 people and has reported -$131,070,000 USD in income.
Stock fluctuations are affected by several factors, from news about the company involved to global trade difficulties or successes.
Despite a tumultuous year with the COVID-19 pandemic, the US stock market overall remained strong in 2021.
Tony Despirito at investment firm BlackRock said “Overall, companies have beat analyst expectations on both earnings per share and revenue growth. But the latter has been particularly strong.”
Nothing in this article is to be assumed as financial advice.
| Company Name | Percentage Change | Current Trading Price |
|---|---|---|
| Diffusion Pharmaceuticals Inc. | 3,095.2% | $8.56 |
| KLDiscovery Inc. | 190% | $5.8 |
| Casa Systems Inc. | 80.7% | $7.1 |
| Golden Star Resource Corp. | -66.3% | $1 |
| Mosaic Immunoengineering Inc. | 57.2% | $1.14 |
| Enservco Corp. | 54.5% | $3.63 |
| Toucan Interactive Corp. | 51.5% | $1.03 |
| MedAvail Holdings Inc. | 50% | $2.16 |
| Cumulus Media Inc. | 42.6% | $14.49 |
| Houston American Energy Corp. | 42.5% | $5 |
| Fovea Jewelry Holdings Ltd. | -38.3% | $3 |
| UC Asset LP | -36.3% | $1.09 |
| Petro Usa Inc. | -33.3% | $6 |
| Cemtrex Inc. | -33.3% | $1 |
| Hugoton Royalty Trust | 32.6% | $1.26 |
| Pyxis Oncology Inc. | -31.1% | $3.12 |
| Advanced Container Technologies Inc. | 29.9% | $1 |
| Natus Medical Inc. | 29.4% | $33.51 |
| TG Therapeutics Inc. | -28.4% | $6.92 |
| Intellinetics Inc. | -28.3% | $4.36 |
| Evolving Systems Inc. | -27.7% | $1.28 |
| Gaucho Group Holdings Inc. | -27.5% | $1.92 |
| Camber Energy Inc. | 27.4% | $1.05 |
| Inrad Optics Inc. | 26.8% | $1.8 |
| Airgain Inc. | 25% | $8.75 |
| Protagonist Therapeutics Inc. | -24.8% | $19.19 |
| Astro Communications Inc. | -24.4% | $2.76 |
| Biofrontera Inc. | -24% | $3.77 |
| Spanish Broadcasting System Inc. | 23.4% | $3.95 |
| Mullen Automotive Inc. | -23.3% | $1.84 |
| Creative Medical Technology Holdings Inc. | -23.2% | $2.25 |
| Nektar Therapeutics | -23.2% | $4.74 |
| Helbiz Inc. | -23% | $2.14 |
| Zymergen Inc. | -22.3% | $1.64 |
| Trevi Therapeutics Inc. | 21.9% | $3.39 |
| Cabaletta Bio Inc. | -20.4% | $1.56 |
| Magenta Therapeutics Inc. | -20.3% | $1.92 |
| Clarus Therapeutics Holdings Inc. | 20.2% | $1.19 |
| Cyteir Therapeutics Inc. | -20.1% | $3.18 |
| Rubius Therapeutics Inc. | -20.1% | $1.71 |
| UserTesting Inc. | -20.1% | $8.8 |
| Ekimas Corp. | 20% | $1.5 |
| Biostem Technologies Inc. | 20% | $1.8 |
| Sana Biotechnology Inc. | -19.9% | $7.49 |
| Verastem Inc. | 19.6% | $1.83 |
| PhaseBio Pharmaceuticals Inc. | -19.1% | $1.23 |
| Adagio Therapeutics Inc. | -18.9% | $3.14 |
| Ayala Pharmaceuticals Inc. | -18.7% | $3.05 |
| Biodesix Inc. | -18.7% | $1.35 |
| Zosano Pharma Corp. | -18.5% | $2.65 |
Alerts Sign-up